Crossmark

Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor

Crossref DOI link: https://doi.org/10.1186/s13041-018-0395-2

Published Online: 2018-09-17

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rodríguez-Muñoz, María

Onetti, Yara

Cortés-Montero, Elsa

Garzón, Javier

Sánchez-Blázquez, Pilar http://orcid.org/0000-0002-7211-4504
Funding

Funding for this research was provided by:

Ministerio de Economía, Industria y Competitividad, Gobierno de España (SAF2015-65420-R)

Ministerio de Sanidad, Servicios Sociales e Igualdad (PND2014-012)
License Information

Text and Data Mining valid from 2018-09-17
More Information

Article History

Received: 8 May 2018

Accepted: 10 September 2018

First Online: 17 September 2018

Ethics approval

: Protocol from animal studies were approved by Consejo Superior de Investigaciones Científicas (CSIC).

: Not applicable.

: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.